StonvexLoading…
StonvexStonvexStonvexCore line items from RGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-25 | Annual 2023 2023-05-27 | Annual 2022 2022-05-28 |
|---|---|---|---|---|
Revenue | $551.33M | $632.80M | $775.64M | $805.02M |
Operating Income | $-196.76M | $28.78M | $72.79M | $83.44M |
Net Income | $-191.78M | $21.03M | $54.36M | $67.17M |
EPS (Diluted) | $-5.80 | $0.62 | $1.59 | $2.00 |
Total Assets | $304.69M | $510.91M | $532.00M | $581.47M |
Total Liabilities | $97.61M | $92.15M | $117.48M | $209.02M |
Cash & Equivalents | $86.15M | $108.89M | $116.78M | $104.22M |
Free Cash Flow OCF − CapEx | $16.19M | $20.78M | $79.62M | $46.48M |
Shares Outstanding | 33.08M | 33.56M | 33.48M | 33.20M |